Oncology The gut microbiome: the next breakthrough in cancer? Ben Hargreaves discovers how research has emerged outlining how the gut microbiome plays a crucial role in patients’ response to cancer treatments.
News Novartis preps key early breast cancer filing for Kisqali NATALEE trial readout sets up Kisqali as rival to Lilly's Verzenio as adjuvant treatment.
News FDA eyes shake-up of swift approval pathway in cancer Regulator wants more use of randomised controlled trials rather than open-label studies.
News Former Seagen CEO Siegall pops up at new biotech Siegall resigned from Seagen last year amid claims of domestic abuse, though was not charged.
News Astellas GLOWing as Claudin drug aces gastric cancer trial Pair of positive phase 3 studies means company will file for approval of zolbetuximab soon.
News Merck suffers a setback in its TIGIT programme Missed endpoint in mid-stage study in lung cancer is a worry after other TIGIT failures.
News Angelini Pharma's R&D chief heads for the exit Dr Rafal Kaminski's near five-year tenure as chief scientific officer of Italy's Angelini Pharma will come to an end in the next couple of weeks.
Sales & Marketing Sponsored Securing your ROI: Turning post-acquisition integration into... Join Forinnovia and Little Cube Consulting for a webinar on securing post-acquisition ROI.